Literature DB >> 16369324

Topics in pediatric leukemia--hematopoietic stem cell transplantation.

Theodore B Moore1, Kathleen M Sakamoto.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16369324      PMCID： PMC1681440     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  23 in total

Review 1.  Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an American view.

Authors:  Allen R Chen; Todd A Alonzo; William G Woods; Robert J Arceci
Journal:  Br J Haematol       Date:  2002-08       Impact factor: 6.998

2.  A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.

Authors:  W G Woods; S Neudorf; S Gold; J Sanders; J D Buckley; D R Barnard; K Dusenbery; J DeSwarte; D C Arthur; B J Lange; N L Kobrinsky
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

3.  Outcome of very late relapse in children with acute lymphoblastic leukemia.

Authors:  Carmelo Rizzari; Maria Grazia Valsecchi; Maurizio Aricò; Roberto Miniero; Chiara Messina; Giulio De Rossi; Anna Maria Testi; Rossella Mura; Stefania Galimberti; Andrea Biondi; Franco Locatelli; Valentino Conter
Journal:  Haematologica       Date:  2004-04       Impact factor: 9.941

4.  A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia.

Authors:  William J Kell; Alan K Burnett; Raj Chopra; John A L Yin; Richard E Clark; Ama Rohatiner; Dominic Culligan; Ann Hunter; Archie G Prentice; Donald W Milligan
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

5.  Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation.

Authors:  Dorothy R Barnard; Beverley Lange; Todd A Alonzo; Jonathan Buckley; J Nathan Kobrinsky; Stuart Gold; Steven Neudorf; Jean Sanders; Laura Burden; William G Woods
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

6.  Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.

Authors:  Anna Nordlander; Jonas Mattsson; Olle Ringdén; Katarina Leblanc; Britt Gustafsson; Per Ljungman; Petter Svenberg; Johan Svennilson; Mats Remberger
Journal:  Biol Blood Marrow Transplant       Date:  2004-03       Impact factor: 5.742

7.  Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.

Authors:  D A Jacobsohn; B Hewlett; M Ranalli; R Seshadri; R Duerst; M Kletzel
Journal:  Bone Marrow Transplant       Date:  2004-11       Impact factor: 5.483

8.  All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

Authors:  Martin S Tallman; Janet W Andersen; Charles A Schiffer; Frederick R Appelbaum; James H Feusner; William G Woods; Angela Ogden; Howard Weinstein; Lois Shepherd; Cheryl Willman; Clara D Bloomfield; Jacob M Rowe; Peter H Wiernik
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

9.  Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

Authors:  Eric L Sievers; Beverly J Lange; Todd A Alonzo; Robert B Gerbing; Irwin D Bernstein; Franklin O Smith; Robert J Arceci; William G Woods; Michael R Loken
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113

10.  Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  M Aricò; M G Valsecchi; B Camitta; M Schrappe; J Chessells; A Baruchel; P Gaynon; L Silverman; G Janka-Schaub; W Kamps; C H Pui; G Masera
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.